Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Phase II trial of neoadjuvant chemotherapy using alternating doublets in non-small-cell lung cancer.

Phase II trial of neoadjuvant chemotherapy using alternating doublets in non-small-cell lung cancer. Clin Lung Cancer. 2007 Jan; 8(4):257-63.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.